This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The first in our inaugural Pharma Horizons report series is dedicated to exploring the latest advances in artificial intelligence (AI) and machine learning (ML) for drug development, pharmaceuticalmanufacturing and quality control. Download for free today!
Aurobindo Pharma-Walk-In Interviews for Freshers in Production/ Packing On 4th Jan’ 2023. Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!! Date : 4th Jan’ 2023.
Aurobindo Pharma-Walk-In Interviews for Quality Control On 4th Mar’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!!
Aurobindo Pharma-Walk-In Interviews for Quality Control/ Production On 7th Jan’ 2023. Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!! Date : 7th Jan’ 2023.
Aurobindo Pharma-Walk-In Interviews for Packing Department On 4th Feb’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!! TA/ Executive/ Sr.
Aurobindo Pharma-Walk-In Interviews for Production/ Quality Control/ Packing On 5th Mar’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!!
Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 28th Jan’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!!
Aurobindo Pharma-Walk-In Interviews for Quality Control On 3rd Feb’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!!
Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 7th Jan’ 2023. Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Greetings from Aurobindo Pharma !!! Date : 7th Jan’ 2023.
Leveraging PAT for environmental monitoring in light of Annex 1 The pharma industry’s adaptation to Industry 4.0 has been slow, due to the extensive regulatory requirements imposed on manufacturers. A key part of Annex 1, due to come into effect on 25 August 2023, is the development of a holistic contamination control strategy (CCS).
APL Health Care (Aurobindo )-Walk-In Interviews for IPQA/ Microbiology On 4th Feb’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8
This step is important as these countries are key markets for pharmaceuticalsmanufacturing. GSK propels its progress to Net Zero Renewable energy in the pharma supply chain The SMI Health Systems Task Force is a public-private partnership launched at COP26.
Granules India Limited- Walk-In Drive for Quality Control Department On 9th Jan’ 2023. Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Walk-In Drive for Quality Control Department On 9th Jan’ 2023 @ Granules India Limited @ Hyderabad.
M&A is an integral part of the lifecycle of pharma companies and a key strategy to future-proof larger players, driving R&D activities and innovation for a competitive product pipeline. Since the first wave of consolidation started in 1988, there has been a significant concentration of the pharma industry.
At the beginning of this year, EPR reported on the potential blockbuster pharmaceutical drugs to watch in 2023. The year 2023 also brought much advancement in the Alzheimer’s space for the pharmaceutical industry. Since then, EPR has covered developments for several of the therapies highlighted in the report.
Granules India Limited- Walk-In Drive for Freshers in Quality Control/ Production/ Warehouse On 16th Feb’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Walk-In Drive for B.Sc / M.Sc/ B.Pharm/ B.Com/ B.A/
Granules India Limited- Walk-In Interviews for Freshers On 7th Jan’ 2023. Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Walk-In Interviews for Freshers On 7th Jan’ 2023 @ Granules India Limited (Gagillapur-Hyderabad). Job Description.
Granules India Limited- Walk-In Interviews for Freshers & Experienced On 5th March 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Granules India Limited- Walk-In Interviews for Freshers & Experienced On 5th March 2023
Aurobindo Pharma-Openings for Freshers – Project Management -Apply Now. Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceuticalmanufacturing firm with turnover of over US$2.8 Year of Passing: 2022 & 2023 only. Greetings from Aurobindo !!!
Looking back at 2023 , AI for drug discovery saw both wins and losses. Manufacturing Optimization While the manufacturing industry lags behind others in terms of AI uptake, there is no shortage of potential ways to leverage this technology. In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%.
Novo Nordisk has announced plans to invest over 42 billion Danish kroner (nearly £5 billion) starting in 2023, to expand its manufacturing facilities in Kalundborg, Denmark. According to the pharma company , the financing will add to global capacity: from manufacturing of active pharmaceutical ingredients (API) through to packaging.
A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. What is driving adoption of quality management systems in pharma? billion by 2030.
Granules India Limited- Walk-In Interviews for Freshers On 16th Feb’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian. Granules India Limited- Walk-In Interviews for Freshers On 16th Feb’ 2023
The global pharmaceutical industry experienced a 23% decline in the number of environmental sustainability-related patent applications in Q1 2023 compared with the previous quarter. The total number of environmental sustainability-related grants dropped by 24% in Q1 2023, according to GlobalData’s Patent Analytics. in Q1 2023.
in 2022 to 1% in 2023 due to the “tightening of monetary and financial conditions”. Furthermore, for months, several financial institutions such as Bank of America and JP Morgan have been talking of a “mild recession” in 2023 for the US. by the end of 2023 and may continue to rise in 2024 to 5%.
SMS Pharmaceuticals Ltd- Walk-Ins for Accounts / Costing/ Finance On 8th Jan’ 2023. SMS Pharmaceuticals Ltd is one of the leading pharmaceuticalmanufacturing companies in India with world -class facilities, with a wide range of process equipment fully compliant with the cGMP and WHO Standards.
The €60 million expansion will open 70 new jobs in sterile manufacturing, quality control and engineering in 2025. Construction at the Carrigtwohill facility built in 2013 is set to begin in 2023. Earlier this year, AbbVie was named Best Workplace for Women and ‘Biopharma Company of the Year’ at the latest Irish Pharma Industry Awards.
Granules India Limited- Walk-In Drive for Capsule Filling / Warehouse/ QC On 17th Feb’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian.
Granules India Limited- Walk-In Drive for Compression/ Granulation/ Packing/ Engineering/ IPQA / QC/ Warehouse On 5th Feb’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian.
And as these stakeholders are presented with more and more RWE from pharmaceuticalmanufacturers, they are asking tough questions to better understand whether to use this evidence when making critical decisions that impact the health of patients.
There has been a steady stream of developments in the vaccine manufacturing space throughout 2023. A notable milestone was Moderna’s announcement in April that it had, following finalisation of a ten-year strategic partnership with the UK Government, commenced construction of its mRNA vaccine manufacturing technology centre.
Granules India Limited- Walk-In Interviews for Freshers in Warehouse/ Production On 17th Mar’ 2023 Job Description Company Profile: Granules India Limited is an Indian pharmaceuticalmanufacturing company based in Hyderabad, Indian.
Pharmaceuticalmanufacturers have submitted Citizen Petitions raising safety or efficacy concerns about proposed competing generic and biosimilar products, and such submissions often delay FDA approval of the proposed products while the FDA resolves the pending petitions.
Sustainable Tech’s Positive Effect on Pharma Funding Recent innovations, including rapid advancements in AI-powered technologies and GLP-1s, have significantly impacted the investment climate and consolidated funding to a smaller number of organizations in the last eight months.
However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).
Of significant interest to the pharma industry are the suggestions in the draft text that money granted for research on infectious diseases could include specifications on how eventual products could be marketed. The next official step will be to deliver a progress report to the 76th World Health Assembly in 2023, which will convene in May.
With the end of the year quickly approaching, you will likely see multiple articles on the key trends of 2023 and predictions for 2024 start popping up. Many of these will discuss the expanding role and capabilities of AI and machine learning in the Pharma space.
However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).
The new funding will establish a new pharmaceuticalmanufacturing scholarship programme – backed with $42.5 million over 10 years – which will support between 75 and 100 students each year, with full tuition plus a guaranteed internship or ‘co-op’ work sessions at Lilly.
PharmaManufacturer Solutions. GM of Manufacturer Solutions. 1 GoodRx’s partnerships with pharmamanufacturers and other key stakeholders in the healthcare industry enable them to offer discounts which have helped patients fill at least 80 million prescriptions that they otherwise could not afford. Patty Riskind.
Container Closure Integrity Testing (CCIT) is used to evaluate the ability of a pharmaceutical’s primary packaging to protect the sterility of its contents. On a regular basis, pharmaceuticalmanufacturers are performing CCIT during commercial production to ensure that packaging processes are operating as they should.
Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] 5] Research is beginning to link PFAS to an increase in kidney cancer rates, reproductive challenges, and thyroid issues. [5]
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content